Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Disparities in Time-to-treatment for Patients With Melanoma.
Popp K, Popp R, Bansal S, Sharan S, Hoorulain S, Sukiam KB, Raikot S, Jimenez PB, Manaise HK, Kowkabany G, Gabriel EM. Popp K, et al. Among authors: popp r. Anticancer Res. 2024 Feb;44(2):631-637. doi: 10.21873/anticanres.16852. Anticancer Res. 2024. PMID: 38307585
Inequities in Time to Treat Thyroid Cancer.
Kowkabany G, Jimenez PB, Sharan S, Bansal S, Ahmed SH, Raikot S, Manaise HK, Popp R, Popp K, Sukniam KB, Gabriel E. Kowkabany G, et al. Among authors: popp r. Anticancer Res. 2023 Nov;43(11):5025-5030. doi: 10.21873/anticanres.16701. Anticancer Res. 2023. PMID: 37909973
Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer.
Jimenez PB, Popp R, Sharan S, Manaise HK, Ahmed SH, Bansal S, Kowkabany G, Raikot S, DO KBS, George A, Gabriel E. Jimenez PB, et al. Among authors: popp r. Anticancer Res. 2023 Nov;43(11):4969-4974. doi: 10.21873/anticanres.16695. Anticancer Res. 2023. PMID: 37909977
Disparities in Time to Treatment for Skin Cancer.
Ahmed SH, Manaise HK, Popp R, Sharan S, Bansal S, Sukniam KB, Raikot SR, Kowkabany G, Jimenez PB, Popp K, Mubarak F, George A, Gabriel E. Ahmed SH, et al. Among authors: popp r. Anticancer Res. 2023 Dec;43(12):5555-5562. doi: 10.21873/anticanres.16757. Anticancer Res. 2023. PMID: 38030200
Methyl α-D-galactopyranosyl-(1→3)-β-D-galactopyranoside and methyl β-D-galactopyranosyl-(1→3)-β-D-galactopyranoside: Glycosidic linkage conformation determined from MA'AT analysis.
Meredith R, Zhu Y, Yoon MK, Tetrault T, Lin J, Zhang W, McGurn M, Cook E, Popp R, Shit P, Carmichael I, Serianni AS. Meredith R, et al. Among authors: popp r. Magn Reson Chem. 2024 Feb 27. doi: 10.1002/mrc.5424. Online ahead of print. Magn Reson Chem. 2024. PMID: 38414300